Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bayer
University of California, Irvine
ViroMissile, Inc.
Essen Biotech
National Institutes of Health Clinical Center (CC)
MacroGenics
Alliance for Clinical Trials in Oncology
University of Nebraska
Adela, Inc
Perspective Therapeutics
Memorial Sloan Kettering Cancer Center
Ocellaris Pharma, Inc.
Var2 Pharmaceuticals
M.D. Anderson Cancer Center